Reuters logo
BRIEF-Alnylam Pharmaceuticals announces positive preliminary results from phase 1 study of ALN-TTRsc02
December 16, 2016 / 12:09 PM / a year ago

BRIEF-Alnylam Pharmaceuticals announces positive preliminary results from phase 1 study of ALN-TTRsc02

Dec 16 (Reuters) - Alnylam Pharmaceuticals Inc

* Alnylam Pharmaceuticals- assuming positive phase 3 data, co plans to submit NDA,marketing authorisation application year-end 2017

* Alnylam Pharmaceuticals Inc - company announces positive preliminary results from phase 1 study of ALN-TTRsc02 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below